Northwest Biotherapeutics SEC Filing Effectiveness

Ticker: NWBO · Form: EFFECT · Filed: Apr 21, 2026 · CIK: 0001072379

Sentiment: neutral

Topics: registration-statement, effectiveness, securities

TL;DR

NWBO filing effective 4/20/26 - registration statement cleared.

AI Summary

Northwest Biotherapeutics Inc. filed an EFFECT form on April 21, 2026, indicating the effectiveness of a registration statement related to securities. The effectiveness date is noted as April 20, 2026. The filing is associated with Act 33 and File No. 333-291044.

Why It Matters

This filing signifies that a registration statement for Northwest Biotherapeutics Inc. has become effective, allowing for the potential sale or issuance of securities.

Risk Assessment

Risk Level: medium — Effectiveness of a registration statement is a procedural step, but the underlying securities offering and market conditions carry inherent risks.

Key Numbers

Key Players & Entities

FAQ

What type of securities are being registered by Northwest Biotherapeutics Inc.?

The filing does not specify the type of securities being registered, only that the registration statement has become effective.

What is the purpose of this EFFECT filing?

The purpose of an EFFECT filing is to notify the SEC that a previously filed registration statement has become effective.

When was the filing accepted by the SEC?

The filing was accepted by the SEC on April 21, 2026.

What is the CIK number for Northwest Biotherapeutics Inc.?

The CIK number for Northwest Biotherapeutics Inc. is 0001072379.

Does this filing indicate a sale of securities has occurred?

No, this filing indicates that the registration statement is effective, which permits the sale of securities, but does not confirm a sale has taken place.

Filing Details

This Form EFFECT (Form EFFECT) was filed with the SEC on April 21, 2026 regarding NORTHWEST BIOTHERAPEUTICS INC (NWBO).

View full filing on EDGAR

View Full Filing

View this EFFECT filing on SEC EDGAR

View on Read The Filing